TY - JOUR AU - Macleod, A. D. PY - 2006 DA - 2006// TI - The management of terminal delirium JO - Indian J Palliat Care VL - 12 UR - https://doi.org/10.4103/0973-1075.25915 DO - 10.4103/0973-1075.25915 ID - Macleod2006 ER - TY - JOUR AU - Bruera, E. AU - Bush, S. H. AU - Willey, J. AU - Paraskevopoulos, T. AU - Li, Z. AU - Palmer, J. L. PY - 2009 DA - 2009// TI - Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers JO - Cancer VL - 115 UR - https://doi.org/10.1002/cncr.24215 DO - 10.1002/cncr.24215 ID - Bruera2009 ER - TY - JOUR AU - Morita, T. AU - Tei, Y. AU - Tsunoda, J. AU - Inoue, S. AU - Chihara, S. PY - 2001 DA - 2001// TI - Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients JO - J Pain Symptom Manage VL - 22 UR - https://doi.org/10.1016/S0885-3924(01)00360-8 DO - 10.1016/S0885-3924(01)00360-8 ID - Morita2001 ER - TY - JOUR AU - Bruera, E. AU - Miller, L. AU - McCallion, J. AU - Macmillan, K. AU - Krefting, L. AU - Hanson, J. PY - 1992 DA - 1992// TI - Cognitive failure in patients with terminal cancer: a prospective study JO - J Pain Symptom Manage VL - 7 UR - https://doi.org/10.1016/0885-3924(92)90074-R DO - 10.1016/0885-3924(92)90074-R ID - Bruera1992 ER - TY - JOUR AU - Stiefel, F. AU - Holland, J. PY - 1991 DA - 1991// TI - Delirium in cancer patients JO - Int Psychogeriatr VL - 3 UR - https://doi.org/10.1017/S1041610291000789 DO - 10.1017/S1041610291000789 ID - Stiefel1991 ER - TY - JOUR AU - Trzepacz, P. T. AU - Teague, G. B. AU - Lipowski, Z. J. PY - 1985 DA - 1985// TI - Delirium and other organic mental disorders in a general hospital JO - Gen Hosp Psychiatry VL - 7 UR - https://doi.org/10.1016/0163-8343(85)90018-0 DO - 10.1016/0163-8343(85)90018-0 ID - Trzepacz1985 ER - TY - JOUR AU - Cobb, J. L. AU - Glantz, M. J. AU - Nicholas, P. K. AU - Martin, E. W. AU - Paul-Simon, A. AU - Cole, B. F. PY - 2000 DA - 2000// TI - Delirium in patients with cancer at the end of life JO - Cancer Pract VL - 8 UR - https://doi.org/10.1046/j.1523-5394.2000.84006.x DO - 10.1046/j.1523-5394.2000.84006.x ID - Cobb2000 ER - TY - JOUR AU - Lacasse, H. AU - Perreault, M. M. AU - Williamson, D. R. PY - 2006 DA - 2006// TI - Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients JO - Ann Pharmacother VL - 40 UR - https://doi.org/10.1345/aph.1H241 DO - 10.1345/aph.1H241 ID - Lacasse2006 ER - TY - JOUR AU - Dial, S. PY - 2002 DA - 2002// TI - Managing acute delirium in the intensive care unit JO - Clin Pulm Med VL - 9 UR - https://doi.org/10.1097/00045413-200209000-00003 DO - 10.1097/00045413-200209000-00003 ID - Dial2002 ER - TY - JOUR AU - Yoon, H. J. AU - Park, K. M. AU - Choi, W. J. AU - Choi, S. H. AU - Park, J. Y. AU - Kim, J. J. PY - 2013 DA - 2013// TI - Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium JO - BMC Psychiatry VL - 13 UR - https://doi.org/10.1186/1471-244X-13-240 DO - 10.1186/1471-244X-13-240 ID - Yoon2013 ER - TY - JOUR AU - Oerther, S. AU - Ahlenius, S. PY - 2000 DA - 2000// TI - Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat JO - J Pharmacol Exp Ther VL - 292 ID - Oerther2000 ER - TY - JOUR AU - Skrobik, Y. K. AU - Bergeron, N. AU - Dumont, M. AU - Gottfried, S. B. PY - 2004 DA - 2004// TI - Olanzapine vs haloperidol: treating delirium in a critical care setting JO - Intensive Care Med VL - 30 UR - https://doi.org/10.1007/s00134-003-2117-0 DO - 10.1007/s00134-003-2117-0 ID - Skrobik2004 ER - TY - JOUR AU - Prommer, E. PY - 2013 DA - 2013// TI - Olanzapine: palliative medicine update JO - Am J Hosp Palliat Care VL - 30 UR - https://doi.org/10.1177/1049909112441241 DO - 10.1177/1049909112441241 ID - Prommer2013 ER - TY - JOUR AU - Elsayem, A. AU - Bush, S. H. AU - Munsell, M. F. AU - Curry, E. AU - Calderon, B. B. AU - Paraskevopoulos, T. PY - 2010 DA - 2010// TI - Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study JO - J Pain Symptom Manage VL - 40 UR - https://doi.org/10.1016/j.jpainsymman.2010.02.017 DO - 10.1016/j.jpainsymman.2010.02.017 ID - Elsayem2010 ER - TY - JOUR AU - Cowan, J. D. AU - Walsh, D. PY - 2001 DA - 2001// TI - Terminal sedation in palliative medicine--definition and review of the literature JO - Support Care Cancer VL - 9 UR - https://doi.org/10.1007/s005200100235 DO - 10.1007/s005200100235 ID - Cowan2001 ER - TY - JOUR AU - Fainsinger, R. L. AU - Moissac, D. AU - Mancini, I. AU - Oneschuk, D. PY - 2000 DA - 2000// TI - Sedation for delirium and other symptoms in terminally ill patients in Edmonton JO - J Palliat Care VL - 16 ID - Fainsinger2000 ER - TY - JOUR AU - Fonte, C. AU - Fatigoni, S. AU - Roila, F. PY - 2015 DA - 2015// TI - A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients JO - Crit Rev Oncol Hematol VL - 95 UR - https://doi.org/10.1016/j.critrevonc.2015.02.010 DO - 10.1016/j.critrevonc.2015.02.010 ID - Fonte2015 ER - TY - JOUR AU - Itoh, S. AU - Teraoka, N. AU - Matsuda, T. AU - Okamoto, K. AU - Takagi, T. AU - Oo, C. PY - 2006 DA - 2006// TI - Reciprocating dialysis tube method: periodic tapping improved in vitro release/dissolution testing of suppositories JO - Eur J Pharm Biopharm VL - 64 UR - https://doi.org/10.1016/j.ejpb.2006.06.004 DO - 10.1016/j.ejpb.2006.06.004 ID - Itoh2006 ER - TY - JOUR AU - Raggi, M. A. AU - Casamenti, G. AU - Mandrioli, R. AU - Izzo, G. AU - Kenndler, E. PY - 2000 DA - 2000// TI - Quantitation of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry JO - J Pharm Biomed Anal VL - 23 UR - https://doi.org/10.1016/S0731-7085(00)00382-4 DO - 10.1016/S0731-7085(00)00382-4 ID - Raggi2000 ER - TY - JOUR AU - Yamazaki, M. AU - Itoh, S. AU - Sasaki, N. AU - Tanabe, K. AU - Uchiyama, M. PY - 1993 DA - 1993// TI - Modification of the dialysis membrane method for drug release from suppositories JO - Pharm Res VL - 10 UR - https://doi.org/10.1023/A:1018933916331 DO - 10.1023/A:1018933916331 ID - Yamazaki1993 ER - TY - JOUR AU - Mimaki, Y. AU - Kawakami, K. AU - Imanaka, C. AU - Suemaru, K. AU - Taniguchi, R. AU - Watanabe, K. PY - 2000 DA - 2000// TI - The effect of the mixed Witepsol base on the drug release from zonisamide suppository JO - Jpn J Hosp Pharm VL - 26 UR - https://doi.org/10.5649/jjphcs1975.26.171 DO - 10.5649/jjphcs1975.26.171 ID - Mimaki2000 ER - TY - JOUR AU - Kuroda, Y. AU - Tokuda, M. AU - Inoue, M. AU - Masuda, K. AU - Terajima, T. AU - Maezawa, K. PY - 2015 DA - 2015// TI - A comparison of the solubility and divisibility of commercial acetaminophen suppository JO - Jpn J Pharm Health Care Sci VL - 41 ID - Kuroda2015 ER - TY - JOUR AU - Boettger, S. AU - Jenewein, J. AU - Breitbart, W. PY - 2015 DA - 2015// TI - Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects JO - Palliat Support Care VL - 13 UR - https://doi.org/10.1017/S1478951514001059 DO - 10.1017/S1478951514001059 ID - Boettger2015 ER - TY - JOUR AU - Kim, S. W. AU - Yoo, J. A. AU - Lee, S. Y. AU - Kim, S. Y. AU - Bae, K. Y. AU - Yang, S. J. PY - 2010 DA - 2010// TI - Risperidone versus olanzapine for the treatment of delirium JO - Hum Psychopharmacol VL - 25 UR - https://doi.org/10.1002/hup.1117 DO - 10.1002/hup.1117 ID - Kim2010 ER - TY - JOUR AU - Callaghan, J. T. AU - Bergstrom, R. F. AU - Ptak, L. R. AU - Beasley, C. M. PY - 1999 DA - 1999// TI - Olanzapine. Pharmacokinetic and pharmacodynamic profile JO - Clin Pharmacokinet VL - 37 UR - https://doi.org/10.2165/00003088-199937030-00001 DO - 10.2165/00003088-199937030-00001 ID - Callaghan1999 ER - TY - JOUR AU - Cavalcanti Bedor, N. C. AU - Galindo Bedor, D. C. AU - Miranda de Sousa, C. E. AU - Nunes Bonifácio, F. AU - da Mota Castelo Branco, D. AU - Bastos Leal, L. PY - 2015 DA - 2015// TI - The development and validation of a method for quantifying olanzapine in human plasma by liquid chromatography tandem mass spectrometry and its application in a pharmacokinetic study JO - Clin Exp Pharmacol Physiol VL - 42 UR - https://doi.org/10.1111/1440-1681.12353 DO - 10.1111/1440-1681.12353 ID - Cavalcanti Bedor2015 ER - TY - JOUR AU - Boer, A. G. AU - Moolenaar, F. AU - Leede, L. G. AU - Breimer, D. D. PY - 1982 DA - 1982// TI - Rectal drug administration: clinical pharmacokinetic considerations JO - Clin Pharmacokinet VL - 7 UR - https://doi.org/10.2165/00003088-198207040-00002 DO - 10.2165/00003088-198207040-00002 ID - Boer1982 ER - TY - JOUR AU - Bergogne-Bérézin, E. AU - Bryskier, A. PY - 1999 DA - 1999// TI - The suppository form of antibiotic administration: pharmacokinetics and clinical application JO - J Antimicrob Chemother VL - 43 UR - https://doi.org/10.1093/jac/43.2.177 DO - 10.1093/jac/43.2.177 ID - Bergogne-Bérézin1999 ER - TY - JOUR AU - Patteet, L. AU - Morrens, M. AU - Maudens, K. E. AU - Niemegeers, P. AU - Sabbe, B. AU - Neels, H. PY - 2012 DA - 2012// TI - Therapeutic drug monitoring of common antipsychotics JO - Ther Drug Monit VL - 34 UR - https://doi.org/10.1097/FTD.0b013e3182708ec5. DO - 10.1097/FTD.0b013e3182708ec5. ID - Patteet2012 ER -